Memorial Sloan Kettering Cancer Center

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

Memorial Sloan Kettering Cancer Center

https://www.mskcc.org/healthcare-professionals

Refer a Patient to MSKCC: mskcc.org/refer

COVID-19
Myeloma
Leukemia
Lymphoma
Hematologic Transplantation and Malignancies
Breast
Lung
Gastrointestinal
Genitourinary
Gynecologic
Skin
Head and Neck
Brain
General Oncology
Palliative Care
Events
MPN

Playback speed

10 seconds

ASCO 2022 HR+ Breast Cancer Updates

By Nebraska Oncology Society FEATURING Chau Dang

589 views

July 6, 2022

This presentation was recorded prior to fam-trastuzumab deruxtecan-nxki (Enhertu) receiving FDA approval on August 5, ...
read more ↘ 2022, for adult patients with HER2-low MBC who have received a prior chemotherapy in the metastatic setting or developed disease recurrence during or within six months of completing adjuvant chemotherapy.
↖ read less

0 Comments